Once the efficacy study is done — the trial that proves definitively that progesterone works as a treatment for moderate to severe TBI — and after it is FDA-approved, progesterone would be a cheap and readily available drug.
See more videos with Dr. David Wright.
About the author: David Wright, MD, FACEP
David Wright, MD is a tenured associate professor in the Department of Emergency Medicine, Emory University, and the director of the division of Emergency Neurosciences.
Produced by Victoria Tilney McDonough, Ashley Gilleland, Justin Rhodes, and Erica Queen, BrainLine.